Skip to main content
DuChemBio Co, LTD logo

DuChemBio Co, LTD — Investor Relations & Filings

Ticker · 176750 ISIN · KR7176750008 KO Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2024-11-08 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 176750

About DuChemBio Co, LTD

http://www.duchembio.com/en/

DuChemBio Co., Ltd. is a pharmaceutical company specializing in the development, manufacturing, and commercialization of radiopharmaceuticals. The company focuses on products for both diagnosis and treatment, with a primary emphasis on positron emission tomography (PET) imaging tracers. Its portfolio targets key therapeutic areas, including oncology for cancer detection and neurology for conditions such as Alzheimer's and Parkinson's disease. The company's mission is to develop novel radiopharmaceuticals and achieve successful commercialization on a global scale.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) for DuchemBio. It details the issuance of new shares, the purpose of the funds, the subscription schedule, and the underwriting process. This type of filing is a formal regulatory announcement concerning capital changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2024-11-08 Korean
증권신고서(지분증권) (2024.11)
Capital/Financing Update Classification · 100% confidence The document is a '증권신고서' (Securities Registration Statement) filed by DuChemBio Co., Ltd. with the Financial Services Commission (FSC) in South Korea. It details a public offering of 1,430,000 shares of common stock. This document is a formal regulatory filing required for public offerings, containing detailed information on the company, investment risks, and the terms of the offering. It is not a periodic report (10-K/IR) or a simple announcement (RPA), but a primary regulatory document for capital raising.
2024-11-08 Korean
기타주요경영사항(자율공시) (코스닥시장 상장예비심사 승인)
Regulatory Filings Classification · 100% confidence The document is a short regulatory announcement from DuChemBio regarding the approval of its preliminary review for KOSDAQ market listing. It is a formal notification of a corporate event (listing progress) rather than a full financial report or a specific category like M&A or dividend. Since it does not fit into the specific categories provided, it falls under the general regulatory filing category.
2024-11-07 Korean
기업설명회(IR)개최결과
Report Publication Announcement Classification · 100% confidence The document is a short, structured announcement detailing the results of an Investor Relations (IR) event held by DuChemBio on October 29, 2024. It lists the date, location, attendees, and agenda items (company introduction, business outlook, Q&A). Since it is a brief notification summarizing the occurrence of an event rather than the full presentation deck or a comprehensive financial report, it falls under the category of a regulatory announcement regarding corporate activities.
2024-10-29 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회 개최). It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it is a short regulatory notice, it falls under the category of a regulatory filing or announcement. Given the specific nature of the announcement regarding an IR event, 'RNS' (Regulatory Filings) is the most appropriate classification as it serves as a general regulatory announcement for corporate events.
2024-10-14 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식처분결과보고서' (Report on the Results of Treasury Stock Disposal) filed by DuchemBio to the Financial Supervisory Service. It details the specific number of shares disposed of (163,279 shares), the disposal date, and the resulting change in the company's treasury stock holdings. This falls under the category of a company reporting the sale or disposal of its own shares, which is classified as 'Transaction in Own Shares' (POS).
2024-08-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.